Om Isofol Isofol Medical AB (publ) är ett biotechbolag verksamt inom onkologi som utvecklar cancerläkemedlet arfolitixorin. Arfolitixorin är en ny läkemedelskandidat som främst är avsett för behandling av kolorektalcancer (CRC), en av de vanligaste formerna av cancer.

22 Jan 2021 Isofol Medical is a Swedish biotech company developing Modufolin, a new folate- based therapy used in the treatment of colorectal cancer and

Revision Date 08/25/2020. Version 1.2. Print Date 08/25/ 2020. 110000001415. Page 1 of 9. SAFETY DATA SHEET.

Isofol

Red Husky, 21-04-09 14:07. Isofol, Jb2020, 21-04-09 12:41. Tålamod. The AGENT Study is conducted at nearly 80 research centers throughout the U.S., Canada and western Europe. This global study is a Phase 3 clinical trial Senaste nyheter om - Isofol Medical, aktieanalys, kursutveckling och rapporter.

Sedan 1997 har vi hjälpt våra kunder att göra vinstgivande aktieaffärer.

Isofol Medical: CEO Ulf Jungnelius presents at Growth Day 2020. Published Isofol Medical: CCO Sven Erickson presenterar på Fight Cancer seminar 10 mars.

Anders Rabbe, VD för Isofol Medical intervjuas av aktiemäklare Pavas Mehra under Pareto Securities årliga health care conference. Isofol Medical. Kontakt. Onkologi i Sverige Tyra lundgrens väg 6 134 40 Gustavsberg.

Isofol avser nå ett marknadsgodkännande baserat på dokumenterade fördelar med Modufolin® jämfört med dagens standardbehandling av i första hand spridd kolorektalcancer. Målet är därav att ersätta Leukovorin och Levoleukovorin, vilka idag utgör en del av standardbehandlingen och ges i samband med cellgiftsbehandling.

These alcohols are characterized by high molecular weight and therefore in-creased boiling points.

They are available with even carbon chain lengths of 12 to 32. While oleyl alcohol starts to solidify at approx. 10° C, ISOFOL alcohol of similar chain lengths remains liquid (Figure 1). Due to the complete saturation, ISOFOLalcohols show excellent oxidative and colour stability (Figure 2). Technical & Safety Data Sheets: Return ISOFOL 16 ALCOHOL : Product Use: Alcohol : Detergents Sasol manufactures ISOFOL Alcohols from both synthetic and natural feedstocks. ISOFOL Alcohols are high purity alcohols which offer excellent oxidative and color stability.
Toyota aktie chf

They are available with even carbon chain lengths of 12 to 32. While oleyl alcohol starts to solidify at approx. 10° C, ISOFOL alcohol of similar chain lengths remains liquid (Figure 1).

Isofol Medical är ett biotechbolag med inriktning mot onkologi. Bolaget utvecklar cancerläkemedlet arfolitixorin.
Deklaration isk konto

haravfall praktisk medicin
skrivare stockholms universitet
aorta screening for aaa
leads generator job
vad tycker sd om invandring
annika hellström swedbank
villkorsavtal t 2021

Visa ISOFOL MEDICAL AB-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser, finansiella ISOFOL-data och marknadsnyheter.

Värdering och villkor. Isofol Medical AB was founded in 2008 based on the research of Professor Bengt Gustavsson and his collaboration with Merck & Cie, the world's leading.

Språkval årskurs 7
stenhuggarverktyg

Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) announces that the independent Data Safety and Monitoring Board (iDSMB) has recommended continuation of the

Arfolitixorin [(R)-enantiomer of folitixorin], an intravenously administered folate-based compound, is being developed by Isofol Medical AB, for the treatment Date HS Code Description Origin Country Port of Discharge Unit Quantity Value (INR) Per Unit (INR) Oct 18 2016: 29051990: ISOFOL 20(2-OCTYL- 1- DODECANOL) Germany: Nhava Sheva Sea Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that a notice that a Clinical Use Patent for the drug candidate arfolitixorin will be approved in Europe. The patent covers a dose regimen for treating solid tumors, such as … Isofol holds a worldwide exclusive license agreement with Merck KGaA, Darmstadt, Germany to develop and commercialize arfolitixorin for oncology indications.